Previous 10 | Next 10 |
Corbus Presents First Pre-Clinical Data for CRB-913 at the European Association for the Study of Diabetes 2022 Annual Conference PR Newswire CRB-913 is a novel oral cannabinoid type 1 receptor (CB1) inverse agonist with potent pre-clinical anti-obesity activity ...
Corbus Pharmaceuticals to Present Virtually at the H.C. Wainwright 24th Annual Global Investment Conference PR Newswire NORWOOD, Mass. , Sept. 12, 2022 /PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), today...
Corbus Pharmaceuticals press release ( NASDAQ: CRBP ): Q2 GAAP EPS of -$0.11. As of June 30, 2022, the Company has $74 million of cash and investments on hand which is expected to fund operations into the first quarter of 2024, based on the current planned expenditures. ...
Corbus Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update PR Newswire Promising pre-clinical data generated for CRB-601 across several tumor models as monotherapy and in combination with anti-PD1 therapy IND submission...
Corbus Presents Latest Preclinical Data for CRB-601 at the New York Academy of Sciences Frontiers in Cancer Immunotherapy Conference PR Newswire CRB-601 is a highly potent and selective anti -αvβ8 integrin monoclonal antibody designed to block t...
Corbus Pharmaceuticals press release (NASDAQ:CRBP): Q1 GAAP EPS of -$0.08 beats by $0.01. As of March 31, 2022, the company has $86.8 million of cash and investments on hand which is expected to fund operations into the first quarter of 2024, based on the current planned expenditures. Promisi...
Corbus Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update PR Newswire Promising pre-clinical data generated for CRB-601 across several tumor models as monotherapy and in combination with anti-PD1 therapy IND submission ...
Corbus Presents First Preclinical Data for CRB-601 at the American Association for Cancer Research (AACR) Annual Meeting PR Newswire NORWOOD, Mass. , April 8, 2022 /PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Comp...
Penny stocks are a great way to make money in the stock market. They’re also an incredible way to take advantage of speculation. Whether it’s weeks leading up to a potential FDA decision, a period of global unrest (like we’ve seen recently), or pending government decisi...
Corbus Pharmaceuticals to Present at the Oppenheimer 32nd Annual Healthcare Conference - Fireside chat with live video webcast on Thursday, March 17th at 8:00 AM ET PR Newswire NORWOOD, Mass. , March 11, 2022 /PRNewswire/ -- Corbus Pharmaceuticals Holdin...
News, Short Squeeze, Breakout and More Instantly...
Corbus Pharmaceuticals Holdings Inc. Company Name:
CRBP Stock Symbol:
NASDAQ Market:
Corbus Pharmaceuticals Holdings Inc. Website:
A look at the top 10 most actives in the United States Serve Robotics Inc. (SERV) rose 187.1% to $7.55 on volume of 255,453,115 shares 60 Degrees Pharmaceuticals Inc. (SXTP) rose 10.2% to $0.271 on volume of 224,640,171 shares NVIDIA Corporation (NVDA) fell 2.6% to $117.93 on volume of 21...
A look at the top 10 most actives in the United States 60 Degrees Pharmaceuticals Inc. (SXTP) rose 98.3% to $0.4878 on volume of 116,444,604 shares NVIDIA Corporation (NVDA) fell 0.2% to $120.8 on volume of 26,900,560 shares Serve Robotics Inc. (SERV) rose 61.2% to $4.2399 on volume of 25...
2024-07-16 13:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...